News

Collegium Pharmaceutical's Engagement in Upcoming Investor Conferences

Collegium Pharmaceutical's Engagement in Upcoming Investor Conferences

Collegium Pharmaceutical's Engagement in Upcoming Investor Conferences

As investors gear up for a busy conference season, Collegium Pharmaceutical, Inc. (Nasdaq: COLL) is poised to showcase its commitment to innovation at several key industry events. The management team is excited to connect with investors and share their vision for future growth and patient-centric solutions.

Participation in Major Healthcare Conferences

Jefferies London Healthcare Conference

One of the highlights on Collegium's schedule is the Jefferies London Healthcare Conference. This engaging event is set for a Wednesday morning, featuring a live presentation from the company’s leadership at 8:00 a.m. GMT. Attendees can look forward to insights into the company's strategic objectives and pipeline developments.

Piper Sandler 37th Annual Healthcare Conference

Following the London event, Collegium will also participate in the Piper Sandler Healthcare Conference. Scheduled for the afternoon of December 2, this fireside chat will offer another platform for Collegium’s executives to engage with investors and discuss the transformative potential of its products. Important details about this event will be accessible through the company's investor segment on their official website.

Evercore Healthcare Conference

The company will round out its conference participation at the Evercore Healthcare Conference, where attendees can gain further understanding of Collegium's strategic direction. This event promises to provide valuable insights as Collegium positions itself within the evolving pharmaceutical landscape.

About Collegium Pharmaceutical, Inc.

Collegium is dedicated to building a diversified biopharmaceutical enterprise with a primary focus on enhancing the quality of life for individuals suffering from serious medical conditions. The company is particularly renowned for its comprehensive portfolio of responsible pain management therapies, fostering improved patient outcomes. Among its flagship offerings is Jornay PM®, which represents a groundbreaking advancement in ADHD treatment.

Guided by a clear growth strategy, Collegium is not only expanding its commercial lineup but also committing to responsible investment choices. Their headquarters in Stoughton, Massachusetts, lends a strong presence in the biopharmaceutical sector, and the company's dedication to patient care is evident through its innovative solutions.

For further records and updates on Collegium’s activities, investors and stakeholders are encouraged to visit their official website, where they keep a repository of archived presentations. These are particularly useful for those unable to attend the live sessions due to scheduling conflicts.

Investor Contacts

Collegium highly values communication with its investor community. The key contacts for investor relations are:

Ian Karp
Head of Investor Relations
ir@collegiumpharma.com

Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com

Frequently Asked Questions

What is Collegium Pharmaceutical known for?

Collegium Pharmaceutical specializes in biopharmaceuticals, focusing on pain management and neuropsychiatry treatments, with Jornay PM® being a significant product in their portfolio.

When will Collegium's presentations take place?

Collegium will present at the Jefferies London Healthcare Conference on November 19 and the Piper Sandler conference on December 2.

How can I access the webcasts of these conferences?

Webcasts of the conferences can be accessed through the Investors section on Collegium's corporate website.

Who can I contact for investor relations inquiries?

For inquiries, you can reach out to Ian Karp or Danielle Jesse, whose contact emails are available in the investor relations section of the Collegium website.

What strategies is Collegium pursuing for growth?

Collegium aims to expand its commercial portfolio and utilize responsible capital deployment to enhance patient care and treatment solutions in their market segments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LG Electronics Expands AI Home Ecosystem at IFA 2026

Updated Category News Views 4

Breaking Down LG’s AI Showcase in Berlin Usually, trade shows don't make me sit up like this—after all, how many times can you be wowed by a washing machine? Yet there's a buzz around LG Electronics' display at IFA 2026 that's got my attention. For folks invested in smart home tech, or just keeping an eye on LG Electronics (because frankly, who isn't?), the company is...

Continue Reading
PGI's Award-Winning Febreze Cabin Air Filters Shines Again

Updated Category News Views 9

A Breath of Fresh Air for the Auto Aftermarket How often do you even think about the quality of air inside your vehicle? If you're like most folks, it's not often. But Premium Guard Inc. (PGI) has been busy changing that narrative. Their Febreze Cabin Air Filters just snagged the 2026 MOTOR Top 20 Awards, proving that they're not just a pretty face in the automotive...

Continue Reading
Allison Ng Earns Prestigious NAPABA 'Best Under 40' Award

Updated Category News Views 0

Allison Ng's Achievement: Beyond the Legal Grind Without warning, the legal world has another star rising up through its ranks, and this time it's Allison Ng catching the spotlight. She’s tucked away in Greenberg Traurig’s Atlanta office, plugging away in pharmaceutical and medical device litigation. But every now and then, these legal eagles get a chance to spread...

Continue Reading
Triskell Debuts in Gartner's 2026 Magic Quadrant

Updated Category News Views 2

Triskell Software Makes Its Mark Kicking off September 2026 with a bang, Triskell Software finds itself on the illustrious 2026 Gartner Magic Quadrant for Adaptive Project Management and Reporting (APMR). This marks the first time the Madrid-based company nabs a spot here, and it's a significant feather in their cap. Just think, out of the 11 vendors invited to this...

Continue Reading
Smithfield's Foreign Lobbying Interests Unveiled Amid Uproar

Updated Category News Views 1

A Behind-the-Scenes Drama Over Lobbying Disclosure Something's fishy beneath the surface of Smithfield Foods' recent lobbying debacle. The Center for Responsible Food Business (CRFB) has turned the spotlight on some shady practices, and folks, it ain't pretty. Smithfield's lobbyists had been ducking disclosure rules apparently meant to keep track of foreign influence. Who...

Continue Reading
October 15 Marks Prologis Q3 2026 Results Call

Updated Category News Views 1

Prologis Steps Up to the Plate This October If you’ve got a finger in any logistic pies, make sure it's wrapped around the latest from Prologis come October 15. The logistics behemoth is rolling out the red carpet for its third quarter results, with all eyes on what their senior management will spill. Frankly, you don’t just show up to these things to sip coffee and...

Continue Reading
OCI Faces Legal Hurdles Amid Merger Efforts

Updated Category News Views 2

OCI Global Gets Twist Thrown Into Merger Plans OCI Global's strategic maneuver with Orascom Construction is hitting a snag. Value8 N.V. has thrown a wrench in the works by filing a petition with Amsterdam's Enterprise Chamber. Looks like this little courtroom tango could pump the brakes on the proposed merger deal. Now, if you're holding shares, it's time to pay attention...

Continue Reading
Finzly Launches AI Security Layer Amid Rising Threats

Updated Category News Views 5

Bank Security in the Age of AI You'd think banks, of all places, were impenetrable fortresses. But these days, they're more like digital targets. With AI-driven attacks becoming as common as morning coffee, Finzly's introducing Assure, an AI-powered security and assurance layer. It's about as timely as ever, given the 89% spike in AI-enabled attacks seen last year. When...

Continue Reading
Mohegan Sun's Star-Studded 30th Year Bash: Details Inside

Updated Category News Views 5

Mohegan Sun Hits the Big 3-0 with a Bang When a casino decides to throw a party, you already know they spare no expense. Mohegan Sun's hitting the big thirty this October, and they've got a lineup that screams celebration. This isn’t just about a glossy red carpet or celebrity sightings, folks. It’s about a milestone that reflects years of stellar entertainment,...

Continue Reading
Hamamatsu & AIxMed to Automate Cytology Workflows

Updated Category News Views 2

Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...

Continue Reading
More News Articles